NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea · Delayed Price · Currency is KRW 17,170
-10 (-0.06%)
Apr 10, 2026, 3:30 PM KST
NeoPharm CO., LTD. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 27,823 | 23,065 | 23,213 | 17,027 | 17,713 |
Depreciation & Amortization | 3,156 | 3,150 | 1,673 | 1,616 | 1,500 |
Loss (Gain) From Sale of Assets | -59.1 | 17.17 | 3.7 | 6.05 | 3.23 |
Asset Writedown & Restructuring Costs | 0.58 | 3.3 | 13.47 | 6.23 | 11.07 |
Loss (Gain) From Sale of Investments | 31.81 | -251.15 | 2.76 | - | -48.48 |
Provision & Write-off of Bad Debts | -89.1 | 320.68 | 95.42 | -0.11 | 55.48 |
Other Operating Activities | -123.26 | -336.03 | 834.24 | 896.16 | 1,416 |
Change in Accounts Receivable | 352.82 | -2,329 | -2,109 | 855.53 | 972.12 |
Change in Inventory | -3,479 | -3,443 | -1,840 | -1,108 | -94.7 |
Change in Accounts Payable | 2,628 | -1,405 | 2,732 | -643.79 | 152.91 |
Change in Other Net Operating Assets | -1,831 | -161.29 | -1,355 | -494.97 | 0.34 |
Operating Cash Flow | 28,410 | 18,631 | 23,263 | 18,161 | 21,681 |
Operating Cash Flow Growth | 52.49% | -19.91% | 28.09% | -16.24% | 26.98% |
Capital Expenditures | -1,185 | -2,799 | -19,852 | -454 | -320.11 |
Sale of Property, Plant & Equipment | 10.2 | - | 0.91 | 0.15 | 0.85 |
Sale (Purchase) of Intangibles | -40.82 | -277.99 | -975.96 | -352.43 | -158 |
Investment in Securities | -7,194 | -3,136 | 4,487 | -8,000 | -16,002 |
Other Investing Activities | -1,002 | -18.97 | 4.02 | 8.57 | -203.9 |
Investing Cash Flow | -9,605 | -6,225 | -16,353 | -8,800 | -16,689 |
Short-Term Debt Repaid | - | - | - | - | -4,000 |
Long-Term Debt Repaid | -749.87 | -598.23 | -534.03 | -494.56 | -373.42 |
Total Debt Repaid | -749.87 | -598.23 | -534.03 | -494.56 | -4,373 |
Net Debt Issued (Repaid) | -749.87 | -598.23 | -534.03 | -494.56 | -4,373 |
Dividends Paid | -9,385 | -5,865 | -5,474 | -5,474 | -5,083 |
Other Financing Activities | -41.49 | -31.47 | 91.79 | 218.63 | -62.13 |
Financing Cash Flow | -10,176 | -6,495 | -5,917 | -5,750 | -9,519 |
Foreign Exchange Rate Adjustments | -38.48 | 442.71 | 4.78 | 223.43 | 387.01 |
Miscellaneous Cash Flow Adjustments | -0 | 0 | 0 | - | - |
Net Cash Flow | 8,590 | 6,353 | 998.06 | 3,834 | -4,140 |
Free Cash Flow | 27,225 | 15,832 | 3,411 | 17,707 | 21,361 |
Free Cash Flow Growth | 71.97% | 364.17% | -80.74% | -17.11% | 27.24% |
Free Cash Flow Margin | 20.60% | 13.30% | 3.51% | 20.82% | 24.29% |
Free Cash Flow Per Share | 1740.59 | 1012.16 | 218.06 | 1132.04 | 1365.69 |
Cash Interest Paid | 29.89 | 37.83 | 20.1 | 8.84 | 39.51 |
Cash Income Tax Paid | 6,406 | 7,125 | 6,363 | 5,716 | 5,069 |
Levered Free Cash Flow | 17,016 | 9,760 | -4,494 | 13,094 | 17,851 |
Unlevered Free Cash Flow | 17,041 | 9,786 | -4,480 | 13,100 | 17,875 |
Change in Working Capital | -2,330 | -7,338 | -2,573 | -1,391 | 1,031 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.